SEC Filing | Nordstrom

View:

SEC FORM 3 SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0104
Estimated average burden
hours per response:			0.5

1. Name and Address of Reporting Person^*

DePree Alexis

(Last)

(First)

(Middle)

C/O NORDSTROM, INC.

1617 6TH AVENUE

(Street)

SEATTLE

98101

(City)

(State)

(Zip)

2. Date of Event Requiring Statement (Month/Day/Year)
01/03/2021

3. Issuer Name and Ticker or Trading Symbol
NORDSTROM INC [ JWN ]

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director	10% Owner
X	Officer (give title below)	Other (specify below)
Chief Supply Chain Officer

5. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)
Common Stock	114,846⁽¹⁾	D

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
1. Title of Derivative Security (Instr. 4)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
Employee Stock Option (right to buy)	06/10/2022	06/01/2030	Common Stock	58,080	16.59	D

Explanation of Responses:

1. Of the total number of shares reported, 1,075 represent shares of common stock and 113,771 represent Restricted Stock Units vesting into shares of common stock in five unequal installments commencing March 10, 2021 and ending March 10, 2024.

Remarks:

	Brian B. DeFoe, Attorney-in-Fact for Alexis DePree	01/07/2021
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

power_ofxattorneyxxdepre

Power of Attorney The undersigned hereby appoints (i) the Executive Vice President, General Counsel and Secretary of Nordstrom, Inc. (currently Ann Munson Steines), and (ii) the Assistant Secretary of Nordstrom, Inc. (currently Brian DeFoe) her true and lawful attorney-in-fact (each an “Appointee” and, collectively, the “Appointees”) to: (1) execute on her behalf, in her capacity as an officer of Nordstrom, Inc. (the “Company”), Forms 3, 4 and 5 and Form ID (collectively, the “Filings”) in accordance with Section 16(a) of the Securities Exchange Act of 1934 and the rules thereunder; (2) do and perform any and all acts on her behalf which may be necessary or desirable to complete and execute the Filings and any amendments to the Filings, and to timely submit such Filings to the United States Securities and Exchange Commission and any stock exchange or similar authority; and (3) take any other action of any type whatsoever in connection with the Filings which, in the opinion of such Appointee, may be in the undersigned’s best interest or may be legally required by her, it being understood that the documents executed by an Appointee on the undersigned’s behalf shall be in such form and shall contain such terms and conditions as such Appointee may approve in the Appointee’s discretion. The undersigned hereby grants to each Appointee full power and authority to do and perform each and every act and thing whatsoever that the Appointee, in the Appointee’s discretion, may believe to be necessary or proper in the exercise of any of the rights and powers granted under this Power of Attorney, as fully as the undersigned might or could do if she were personally present. The undersigned hereby grants each Appointee full power of substitution or revocation with respect to this appointment, and ratifies and confirms all that such Appointee, or such Appointee’s substitute or substitutes, shall lawfully do or cause to be done by virtue of this Power of Attorney and the rights and powers granted under this Power of Attorney. The undersigned acknowledges that each Appointee, in serving in such capacity at her request, is not assuming, nor is the Company assuming, any of her responsibilities to comply with Section 16 of the Securities Exchange Act of 1934. The undersigned agrees to hold harmless the Company and the Appointees for the performance of the foregoing actions in the exercise of any rights and powers herein granted. This Power of Attorney shall remain in full force and effect with respect to the undersigned until she is no longer required to submit Filings with respect to holdings of and transactions in securities issued by the Company, unless earlier revoked by the undersigned in a signed writing delivered to the Appointees and the Company. Officer: Dated this __________ day of December 2020. Alexis DePree DocuSign Envelope ID: D1A1AE50-8788-4C8A-8661-E85591D11A6B 18